VD VDR

VD VDR

Vitamin D is a secosteroidalprohormone, it can be synthesized at sufficient levels in skin, given adequate skin exposure to UV B radiation from sunlight.By directly controlling target gene expression through the Vitamin D receptor (VDR), a ligand-regulated transcription factor and member of the nuclear receptor superfamily, vitamin D modifies its biological effects. Vitamin D must undergo two hydroxylation steps in order to become the biologically active hormone 1,25-dyhydroxyvitamin D3 [1,25(OH)2D3], which communicates through the VDR, whether it is produced in the skin or consumed. In reaction to vitamin D, the hormone-bound VDR modifies target gene transcription. VDR controls autophagy's transcription at the master level. In breast cancer (BC) cells, vitamin D-activated VDR causes autophagy and an autophagic transcriptional signature.

Vitamin D comes in two different forms. Vitamin D3 (cholecalciferol) is produced in the skin and is found in oily fish and cod liver oil. Vitamin D2 (ergocalciferol) is produced by irradiating yeast and the plant sterol ergosterol. Vitamin D stands for vitamins D2 and D3.

For the treatment of psoriasis, topical medications containing active vitamin D3 (calcitriol, 1,25-dihydroxyvitaminD3, VD3) analogues, such as Tacalcitol, Calcipotriol, and Maxacalcitol, are frequently utilized.

VD VDR related products

Structure Cat No. Product Name CAS No. Product Description
V24327 Maxacalcitol (22-Oxacalcitriol) 103909-75-7 Maxacalcitol (22-Oxacalcitriol)is a novel calcitriol analog without hypercalcemic side effects.
V41330 Maxacalcitol-D6 Maxacalcitol-D6 is the hexa-deuterated form (at the 26,27-dimethyl group) of Maxacalcitol which is a novel calcitriol analog without hypercalcemic side effects.
V67833 MeTC7 1817841-22-7 MeTC7 is a vitamin D receptor (VDR) antagonist.
V5288 Paricalcitol (Zemplar) 131918-61-1 Paricalcitol (trade name Zemplar) is a novel and potent vitamin D receptor (VDR) agonist developed by Abbott Laboratories for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.
V67839 Previtamin D3 1173-13-3 Previtamin D3 is an intermediate in the preparation /synthesis of cholecalciferol (vitamin D3).
V67841 Pyrocholecalciferol 10346-43-7 Pyrocholecalciferol A vitamin D analog generated by the photochemical conversion of 7-dehydrocholesterol (7-DHC).
V63206 Secalciferol-d6 ((24R)-24,25-Dihydroxyvitamin D3-d6) 1440957-55-0 Secalciferol-d6 is the deuterated form of Secalciferol.
V5290 Tacalcitol [1,24(R)-Dihydroxyvitamin D3] 57333-96-7 Tacalcitol [1,24(R)-Dihydroxyvitamin D3; 1.alpha.,24R-Dihydroxyvitamin D3] is a vitamin D3 analog (isomer of Vitamin D3) that promotes normal bone development by regulating calcium.
V12071 TEI-9647 173388-20-0 TEI-9647 (TEI9647) is a vitamin D receptor (VDR) antagonist with immunomodulatory effects.
V67834 TEI-9648 173388-21-1 TEI-9648 is a Vitamin D3 Lactone analogue that is a potent and specific vitamin D receptor (VDR) antagonist.
V81726 VDR agonist 2 VDR agonist 2 (compound 16i) is a VDR (vitamin D receptor) agonist that can effectively inhibit TGF-β1-induced activation of hepatic stellate cells (HSC).
V5286 Vitamin D2 (Ergocalciferol) 50-14-6 Vitamin D2 (Ergocalciferol; Calciferol; Ercalciol) is one form of vitamin D with a double bond on the side chain, which differentiates it from Vitamin D3 (without a double bond on the side chain).
V67837 Vitamin D2-d6 (Ergocalciferol-d6; Calciferol-d6; Ercalciol-d6) 1311259-89-8 Vitamin D2-d6 is the deuterium labelled form of Vitamin D2.
V67838 Vitamin D3-d7 (vitamin D3 d7) 1627523-19-6 Vitamin D3-d7 is the deuterium labelled form of Vitamin D3.
V5284 Vitamin D4 511-28-4 Vitamin D4 (22-Dihydroergocalciferol) is a form of vitamin D developed from fungi.
V78432 Vitamin D4-d5 (22-Dihydroergocalciferol-d5) Vitamin D4-d5 is the deuterium labelled form of Vitamin D4.
Contact Us Back to top